Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP ...
"Choice is power," said Mark Bertolini, CEO of Oscar Health. "Oscar's lineup of new products bring surprising new experiences and rewards to help members manage their health and get the most out of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback